Back to results
US 11,304,973 B2Granted
Botulinum toxin and colloidal silver particles
AssigneesAmerican Silver, LLC, Dr. Andrew Willoughby Inc.
InventorsKeith William Moeller, Andrew J. M. Willoughby
Life of this patent
Estimating the term…
Abstract
Botulinum toxin is combined with colloidal silver particles to provide improved compositions for use in medical and cosmetic treatments.
Claims4
A method of treating wrinkles, comprising
- administering a composition by injection to a subject in need thereof, the composition comprising botulinum toxin (BTX), colloidal silver particles, and at least one of water, saline and buffer, the composition comprising from 10±5 ppm to 30±5 ppm colloidal silver particles for every 100 units of BTX suspended in the water, and wherein the colloidal silver particles are in the form of a stable and colorless colloidal suspension of silver particles having an interior of metallic silver and an exterior surface of ionic silver oxide, wherein at least 75% of the silver particles have diameters between 0.005 micrometers and 0.015 micrometers, and
- storing the composition for a period of from 2 weeks to 4 months after preparation of the composition, prior to the administering of the composition to the subject;
- and
- wherein the administration is effective to treat static or functional wrinkles for a period of 7.5 months to 10 months.
1 more element
A method of treating wrinkles, comprising
- administering a composition by injection to a subject in need thereof, the composition comprising botulinum toxin (BTX), colloidal silver particles, and water, the composition comprising an amount of from 10±5 ppm to 30±5 ppm colloidal silver particles for every 100 units of BTX suspended in the water where the amount is effective to treat static or functional wrinkles for a period of 7.5 months to 10 months, and wherein the colloidal silver particles are in the form of a stable and colorless colloidal suspension of silver particles having an interior of metallic silver and an exterior surface of ionic silver oxide, wherein at least 75% of the silver particles have diameters between 0.005 micrometers and 0.015 micrometers.
Dependencies are inferred from the claim text.